7O0K image
Deposition Date 2021-03-26
Release Date 2021-05-12
Last Version Date 2024-01-31
Entry Detail
PDB ID:
7O0K
Title:
Crystal structure of recombinant chichen liver Bile Acid Binding Protein (cL-BABP) in complex with cholic acid
Biological Source:
Source Organism:
Gallus gallus (Taxon ID: 9031)
Method Details:
Experimental Method:
Resolution:
1.83 Å
R-Value Free:
0.28
R-Value Work:
0.23
R-Value Observed:
0.23
Space Group:
P 21 21 21
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Fatty acid-binding protein, liver
Gene (Uniprot):FABP1
Chain IDs:A, B
Chain Length:129
Number of Molecules:2
Biological Source:Gallus gallus
Ligand Molecules
Primary Citation
Validation of Recombinant Chicken Liver Bile Acid Binding Protein as a Tool for Cholic Acid Hosting.
Biomolecules 11 ? ? (2021)
PMID: 33925706 DOI: 10.3390/biom11050645

Abstact

Bile acids (BAs) are hydroxylated steroids derived from cholesterol that act at the intestinal level to facilitate the absorption of several nutrients and also play a role as signaling molecules. In the liver of various vertebrates, the trafficking of BAs is mediated by bile acid-binding proteins (L-BABPs). The ability to host hydrophobic or amphipathic molecules makes BABPs suitable for the distribution of a variety of physiological and exogenous substances. Thus, BABPs have been proposed as drug carriers, and more recently, they have also been employed to develop innovative nanotechnology and biotechnology systems. Here, we report an efficient protocol for the production, purification, and crystallization of chicken liver BABP (cL-BABP). By means of target expression as His6-tag cL-BABP, we obtained a large amount of pure and homogeneous proteins through a simple purification procedure relying on affinity chromatography. The recombinant cL-BABP showed a raised propensity to crystallize, allowing us to obtain its structure at high resolution and, in turn, assess the structural conservation of the recombinant cL-BABP with respect to the liver-extracted protein. The results support the use of recombinant cL-BABP for the development of drug carriers, nanotechnologies, and innovative synthetic photoswitch systems.

Legend

Protein

Chemical

Disease

Primary Citation of related structures